RVPH - Reviva Pharma slips on $30M stock offering
2023-11-16 08:30:43 ET
More on Reviva Pharmaceuticals
- Reviva Pharmaceuticals: Positive Results In Phase 3 But The Stock Is Back Where It Started
- Reviva Pharmaceuticals: A Binary Event Approaches With Results From RECOVER
- Reviva posts late-stage data for schizophrenia candidate
- Seeking Alpha’s Quant Rating on Reviva Pharmaceuticals
- Historical earnings data for Reviva Pharmaceuticals
For further details see:
Reviva Pharma slips on $30M stock offering